Automation index
How much of a Maxillofacial surgeon’s job can AI already do?
A 3D osteotomy plan comes earlier. Cutting the jaw and getting the bite to fit do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Maxillofacial surgeon
21%
AI can already do 21% of this job.
#424 / 653
View rankingMaxillofacial surgeon
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
3D plan, splints and consent.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Osteotomies, facial trauma and implants.EstimateNo public source provides a precise figure. This is our estimate. | 22% | 8% | +1.8 |
Cyst, impacted wisdom tooth and the joint.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Post-op, occlusion and the face that swells.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
Head and neck oncology with the board.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 18% | +2.9 |
Facial emergencies and signing the bone that moves.EstimateNo public source provides a precise figure. This is our estimate. | 14% | 12% | +1.7 |
| Total | 100% | 21% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- osteotomy
- facial trauma
- zygomatic implants
- impacted wisdom teeth
- occlusion
- 3D maxillofacial plan
- jaw cysts
- head and neck
Sources for this job· O*NET 29-1022.00· ESCO/ISCO 2261
IS WORK OVER?
Clinical research associate
27%
#172 / 653
View rankingClinical research associate
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Protocol, CRF and the monitoring visit.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Source, the gap and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Adverse event, the deadline and not delaying.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Consent, the signature and the one who did not understand.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The sponsor, the audit and not dressing the figure.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Audit, and not leaving a made-up figure.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- CRF
- monitoring
- adverse events
- informed consent
- source data
- trial audits
- clinical protocols
- site visits
Sources for this job· O*NET 11-9121.00· ESCO/ISCO 2131